| Merck/Schering-Plough Pharmaceuticals Provides Results of the ENHANCE Trial
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.--(BUSINESS WIRE)--Merck/Schering-Plough Pharmaceuticals announced today the primary endpoint and other results of the ENHANCE (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia) trial. Merck/Schering-Plough has submitted an abstract on the ENHANCE trial for presentation at the American College of Cardiology meeting, which will be held in March 2008, and is awaiting notification of acceptance from the College. .
Dec 28th
Well, it's almost time for me to head off to Australia. Tomorrow, actually, but this might be my last chance to get in a blog before then. I will try to blog while there but won't promise. Christmas is over and it was quite a pleasant one. My son visited from Las Vegas and he said he had a good time. It looks like he is set on going back to college full time to qualify as an accountant. He did one class last semester and got an A, so it looks like he should do OK in that field. He has quite a bit of money coming to him for education from the time he spent in the United States Air Force; at least enough for about two years of college. We spent Christmas Eve morning at my wife's parents then headed to Pensacola Beach, Florida to where my wife's sister and family live. Lots of gifts were handed around and we all ate and drank too much.
Personally Identifying Information (PIN)
If, at any time, you do not want us to share your information with third parties who wish to send you information about their products and services, you may opt-out of such messages by going to the "Manage an Account" page and simply unclicking an opt-in box or you may email us at privacycoordinator@medianewsgroup.com or write to us at: Privacy Coordinator, MediaNews Group, 1560 Broadway, Ste. 2100, Denver, CO 80202. If you choose to opt-out via email, please put "THIRD PARTY OPT-OUT" in the subject line, along with the name of the applicable site. MediaNews Opt-Out: If, at any time, you do not want to receive information about special offers and new products and features from MediaNews, you may opt-out of such messages by going to the "Manage an Account" page and simply unclicking an opt-in box or you may e-mail us at privacycoordinator@medianewsgroup.com or write to us at: Privacy Coordinator, MediaNews Group, 1560 Broadway, Ste.
|
